Special Issue

Topic: Drug Resistance Mechanisms in Cancer

A Special Issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 31 May 2019

Guest Editor(s)

Dr. Helen M. Coley
Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Special Issue Introduction

The Special Issue on "Drug Resistance Mechanisms in Cancer" will include Reviews and Commentaries updating the problem of drug resistance in the clinic and how attempts have/are being made to improve the situation via laboratory-based research approaches. Aspects of drug resistant disease for different tumor types with a mechanistic basis e.g. breast, lung, melanoma, colon cancers will be covered in this issue alongside any advances made in the identification of biomarkers of drug responsiveness. The Special Issue will also include Research articles presenting novel outstanding data on all aspects of drug resistance mechanisms in cancer. All submissions will undergo rigorous peer review and will be published free of charge upon acceptance.

Keywords

Drug resistant cancers, resistance modulation, multidrug resistance, chemotherapy resistance, targeted therapy resistance, biomarkers of drug responsiveness

Submission Deadline

31 May 2019

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr
Submission Deadline: 31 May 2019
Contacts: Elaine Gao, Managing Editor, editorial@cdrjournal.com
                  Ellie Liang, Editor, ellie.liang@oaepublish.com

Published Articles

RET in breast cancer: pathogenic implications and mechanisms of drug resistance
Open Access Review
Views: Downloads:
Download PDF
Network rewiring, adaptive resistance and combating strategies in breast cancer
Open Access Review
Views: Downloads:
Download PDF
In search of effective therapies to overcome resistance to Temozolomide in brain tumours
Open Access Review
Views: Downloads:
Download PDF
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
Open Access Review
Views: Downloads:
Download PDF
Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology
Open Access Review
Views: Downloads:
Download PDF
Mitochondrial determinants of chemoresistance
Open Access Review
Views: Downloads:
Download PDF
Role of circulating tumor cell spheroids in drug resistance
Open Access Review
Views: Downloads:
Download PDF
Mechanisms of resistance to anti-angiogenic treatments
Open Access Review
Views: Downloads:
Download PDF
Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistance
Open Access Perspective
Views: Downloads:
Download PDF
Stress and drug resistance in cancer
Open Access Review
Views: Downloads:
Download PDF
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
Open Access Review
Views: Downloads:
Download PDF
Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors
Open Access Review
Views: Downloads:
Download PDF
Targeting the “undruggable” RAS - new strategies - new hope?
Open Access Review
Views: Downloads:
Download PDF
The effects of growth hormone on therapy resistance in cancer
Open Access Review
Views: Downloads:
Download PDF
Molecular mechanisms of enzalutamide resistance in prostate cancer
Open Access Review
Views: Downloads:
Download PDF
New insights into acquired endocrine resistance of breast cancer
Open Access Review
Views: Downloads:
Download PDF
Mechanism of resistance to immune checkpoint inhibitors
Open Access Review
Views: Downloads:
Download PDF
Drug resistance and combating drug resistance in cancer
Open Access Review
Views: Downloads:
Download PDF
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/